| 251 |
8615170 | Effects of catechol-O-methyltransferase (COMT) inhibition on the pharmacokinetics of L-DOPA. | 1996 |
2 |
| 252 |
8726541 | Effect of one month's treatment with peripherally acting catechol-O-methyltransferase inhibitor, entacapone, on pharmacokinetics and motor response to levodopa in advanced parkinsonian patients. | 1996 Jun |
2 |
| 253 |
8807664 | Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. | 1996 Jun |
2 |
| 254 |
8836986 | The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients. | 1996 Jul |
2 |
| 255 |
8941353 | No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase. | 1996 Nov 21 |
1 |
| 256 |
7651456 | Effects of tolcapone in Parkinson's patients taking L-dihydroxyphenylalanine/carbidopa and selegiline. | 1995 May |
1 |
| 257 |
8527287 | Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa. | 1995 Sep |
1 |
| 258 |
8635184 | Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, Parkinson's disease. | 1995 Jun |
2 |
| 259 |
8665534 | Effect of entacapone, a COMT inhibitor, on the pharmacokinetics and metabolism of levodopa after administration of controlled-release levodopa-carbidopa in volunteers. | 1995 Feb |
1 |
| 260 |
8665546 | Acute effects of COMT inhibition on L-DOPA pharmacokinetics in patients treated with carbidopa and selegiline. | 1995 Aug |
2 |
| 261 |
8787797 | Pharmacokinetic model of oral levodopa and role of carbidopa in parkinsonian patients. | 1995 Dec |
1 |
| 262 |
7834959 | [The effect of droxidopa on the monoamine metabolsim in the human brain]. | 1994 Oct |
2 |
| 263 |
7952244 | New medical and surgical treatments for Parkinson's disease. | 1994 Aug |
2 |
| 264 |
8035323 | Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans. | 1994 Jul |
2 |
| 265 |
8070503 | Low catechol-O-methyltransferase activity in a Saami population. | 1994 |
1 |
| 266 |
8126502 | Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease. | 1994 Feb |
4 |
| 267 |
8127373 | Crystal structure of catechol O-methyltransferase. | 1994 Mar 24 |
1 |
| 268 |
8190296 | Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients. | 1994 May |
5 |
| 269 |
27520516 | Clinical Potential of Catechol-OMethyltransferase (COMT) Inhibitors as Adjuvants in Parkinson's Disease. | 1994 Mar |
2 |
| 270 |
8112370 | Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease. | 1993 |
1 |
| 271 |
8255478 | Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients. | 1993 Dec |
1 |
| 272 |
8341294 | Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa. | 1993 Jul |
2 |
| 273 |
8477410 | The effect of catechol-O-methyl transferase inhibition by entacapone on the pharmacokinetics and metabolism of levodopa in healthy volunteers. | 1993 Apr |
3 |
| 274 |
1584187 | Treatment strategies for extension of levodopa effect. | 1992 May |
1 |
| 275 |
1734304 | [18F]-6-fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR-462). | 1992 Jan |
1 |
| 276 |
1875781 | Catechol-O-methyltransferase and aromatic L-amino acid decarboxylase activities in human gastrointestinal tissues. | 1991 |
3 |
| 277 |
1884738 | Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone. | 1991 |
1 |
| 278 |
1958292 | (-)-Deprenyl treatment of patients with Parkinson's disease does not affect erythrocyte catechol-O-methyl transferase activity. | 1991 |
3 |
| 279 |
2272023 | Effect of a novel catechol-O-methyltransferase inhibitor, nitecapone, on the metabolism of L-dopa in healthy volunteers. | 1990 Oct |
2 |
| 280 |
2289048 | L-dopa as substrate for human duodenal catechol-O-methyltransferase and aromatic L-amino acid decarboxylase. | 1990 Nov |
1 |
| 281 |
6437857 | The pharmacology of Parkinson's disease: basic aspects and recent advances. | 1984 Nov 15 |
1 |
| 282 |
6714437 | Human pharmacogenetics of methyl conjugation. | 1984 May 15 |
1 |
| 283 |
6734032 | Difference in erythrocyte catechol-O-methyltransferase activity between Orientals and Caucasians: difference in levodopa tolerance. | 1984 Jun |
2 |
| 284 |
7121609 | Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa. | 1982 Jul |
1 |
| 285 |
7137962 | 3-O-methyldopa blocks dopa metabolism in rat corpus striatum. | 1982 Sep |
1 |
| 286 |
7296879 | Determination of free and conjugated catecholamines and L-3,4-dihydroxyphenylalanine in plasma and urine: evidence for a catechol-O-methyltransferase inhibitor in uraemia. | 1981 Sep |
1 |
| 287 |
7398195 | Catechol-O-methyltransferase activity: a determinant of levodopa response. | 1980 Aug |
5 |
| 288 |
847319 | [Abnormal movements of patients with Parkinsonism treated with L-dopa and anomalies of dopamine metabolism]. | 1977 Jan |
1 |
| 289 |
5016575 | Metabolism of L-dopa after inhibition of catechol-O-methyl transferase. | 1972 Jan |
1 |
| 290 |
5112212 | Potentiation of the L-Dopa effect in man by the use of catechol-O-methyltransferase inhibitors. | 1971 Oct |
1 |